93 related articles for article (PubMed ID: 23701395)
1. Haemangioma: clinical course, complications and management.
Luu M; Frieden IJ
Br J Dermatol; 2013 Jul; 169(1):20-30. PubMed ID: 23701395
[TBL] [Abstract][Full Text] [Related]
2. Successful sirolimus treatment of spindle cell haemangiomas in a paediatric patient with Maffucci syndrome.
He R; Wang Y; Ma L; Zhang N; Zhang B
Clin Exp Dermatol; 2024 Apr; 49(5):540-542. PubMed ID: 38197561
[No Abstract] [Full Text] [Related]
3. Use of propranolol in infantile haemangiomas: report of five cases and review of the literature.
Gidaris D; Economou M; Hatzidemetriou V; Gombakis N; Athanassiou-Metaxa M
Hippokratia; 2011 Jan; 15(1):81-3. PubMed ID: 21607042
[TBL] [Abstract][Full Text] [Related]
4. Infantile and congenital hemangiomas.
Liang MG; Frieden IJ
Semin Pediatr Surg; 2014 Aug; 23(4):162-7. PubMed ID: 25241092
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of infantile hemangiomas.
Püttgen KB
Pediatr Clin North Am; 2014 Apr; 61(2):383-402. PubMed ID: 24636652
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of noninvoluting congenital hemangioma: a retrospective review.
Lee PW; Frieden IJ; Streicher JL; McCalmont T; Haggstrom AN
J Am Acad Dermatol; 2014 May; 70(5):899-903. PubMed ID: 24630000
[TBL] [Abstract][Full Text] [Related]
7. Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature.
Nasseri E; Piram M; McCuaig CC; Kokta V; Dubois J; Powell J
J Am Acad Dermatol; 2014 Jan; 70(1):75-9. PubMed ID: 24176519
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and risk factors for infantile hemangioma--a case control study.
Rasul S
Eur J Pediatr Surg; 2014 Feb; 24(1):102-12. PubMed ID: 24008548
[TBL] [Abstract][Full Text] [Related]
9. Therapy of ulcerated hemangiomas.
McCuaig CC; Cohen L; Powell J; Hatami A; Marcoux D; Maari C; Caouette-Laberge L; Bortoluzzi P; Ondrejchak S; Dubois J
J Cutan Med Surg; 2013; 17(4):233-42. PubMed ID: 23815955
[TBL] [Abstract][Full Text] [Related]
10. Infantile Hemangioma of the Breast: Long-Term Assessment of Outcomes.
Labow BI; Alshamekh SA; Carlberg VM; Zacur JL; Uihlein LC; Mulliken JB; Liang MG
Plast Reconstr Surg Glob Open; 2024 Jan; 12(1):e5506. PubMed ID: 38196847
[TBL] [Abstract][Full Text] [Related]
11. A retrospective 10 years- experience overview of dye laser treatments for vascular pathologies.
Giovanni C; Marina PB; Tiziano Z
Skin Res Technol; 2023 Aug; 29(8):e13427. PubMed ID: 37632184
[TBL] [Abstract][Full Text] [Related]
12. A Cosmetic Approach to Cheek and Nasal Hemangioma Utilizing Open Rhinoplasty in a 10-Year-Old Child: A Case Report.
Mrad MA; AlMarshad FA; AlZahrani AM; Obeid DA; Alsinan TA; AlOtaibi AS
Cureus; 2023 Jan; 15(1):e34185. PubMed ID: 36843783
[TBL] [Abstract][Full Text] [Related]
13. A transcription factor is the target of propranolol treatment in infantile hemangioma.
Schrenk S; Boscolo E
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 35104803
[TBL] [Abstract][Full Text] [Related]
14. Infantile hemangiomas: risk factors for complications, recurrence and unaesthetic sequelae.
Mariani LG; Ferreira LM; Rovaris DL; Bonamigo RR; Kiszewski AE
An Bras Dermatol; 2022; 97(1):37-44. PubMed ID: 34848114
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of oral propranolol for infantile hemangioma on the head and neck region: A case series.
Kreshanti P; Putri NT; Martin VJ; Sukasah CL
Int J Surg Case Rep; 2021 Jul; 84():106120. PubMed ID: 34216913
[TBL] [Abstract][Full Text] [Related]
16. Sleep behavior of infants with infantile hemangioma treated with propranolol-a cohort study.
Theiler M; Knöpfel N; von der Heydt S; Schwieger-Briel A; Luchsinger I; Smith A; Kernland-Lang K; Waelchli R; Neuhaus K; Kohler M; Gnannt R; Schoch SF; Weibel L; Kurth S
Eur J Pediatr; 2021 Aug; 180(8):2655-2668. PubMed ID: 34143243
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas.
Phillips JD; Merrill T; Gardner JR; Thomas Collins R; Sanchez J; Johnson AB; Eble BK; Hartzell LD; Kincannon JM; Richter GT
Int J Pediatr; 2021; 2021():6657796. PubMed ID: 33679994
[TBL] [Abstract][Full Text] [Related]
18. Oral atenolol treatment for infantile hemangiomas: clinical analysis of 133 consecutive patients.
Zhao ZL; Liu C; Wang QZ; Wu HW; Zheng JW
Ann Transl Med; 2021 Jan; 9(2):116. PubMed ID: 33569418
[TBL] [Abstract][Full Text] [Related]
19. Impact of congenital cutaneous hemangiomas on newborn care in the United States.
Tripathi R; Mazmudar RS; Knusel KD; Ezaldein HH; Belazarian LT; Bordeaux JS; Scott JF
Arch Dermatol Res; 2021 Oct; 313(8):641-651. PubMed ID: 33078272
[TBL] [Abstract][Full Text] [Related]
20. Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210.
Chen X; Ma L; Wang X; Mo H; Wu D; Lan B; Qu D; Zhang H; Huang J; Xu B
Cancer Biol Med; 2019 Feb; 16(1):173-181. PubMed ID: 31119058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
